<?xml version="1.0" encoding="UTF-8"?>
<p>Before ACE2 reaches the lysosomes, SARS-CoV-2 escapes by fusing with the endosomal membrane, relocating into the cytoplasm where it can replicate.
 <xref rid="pvaa053-B14" ref-type="bibr">
  <sup>14</sup>
 </xref> Normally, when ACE2 reaches the lysosomes, NO is produced,
 <xref rid="pvaa053-B24" ref-type="bibr">
  <sup>24</sup>
 </xref> which is thought to reduce viral replication
 <xref rid="pvaa053-B25" ref-type="bibr">
  <sup>25</sup>
 </xref> and initiate a virus-specific immune response.
 <xref rid="pvaa053-B26" ref-type="bibr">
  <sup>26</sup>
 </xref> This lysosomal NO down-regulates AT1R, prompting AngII to activate AT2R. AT2R then induces the production of ACE2, which in turn converts AngII into Ang(1-7), which further induces the production of NO, necessary for the adaptive immune response
 <xref rid="pvaa053-B27" ref-type="bibr">
  <sup>27</sup>
 </xref> (
 <italic>FigureÂ 
  <xref ref-type="fig" rid="pvaa053-F2">2</xref>
 </italic>). In parallel, inflammation is reduced and the virus-specific immunity starts replacing non-specific inflammatory responses.
 <xref rid="pvaa053-B27" ref-type="bibr">
  <sup>27</sup>
 </xref>
</p>
